[RGLS] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
08-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 25.81%
YoY- 35.10%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 18 6,778 18 18 18 18 18 0.00%
PBT -5,015 -3,260 -8,502 -10,273 -13,847 -16,024 -14,506 -50.83%
Tax 1 56 61 201 118 1 -58 -
NP -5,016 -3,260 -8,563 -10,273 -13,847 -16,025 -14,448 -50.69%
Tax Rate - - - - - - - -
Total Cost 5,034 10,038 8,581 10,291 13,865 16,043 14,466 -50.62%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -27,866.67 -48.10 -47,572.22 -57,072.22 -76,927.78 -89,027.78 -80,266.67 -50.69%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -3.00 -3.14 -9.75 -11.80 -15.93 -18.49 -16.68 -68.23%
EPS Diluted -3.00 -3.14 -9.75 -11.80 -15.93 -18.49 -16.68 -68.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.